The HIV Collective is a community campaign that has been developed and paid for by Gilead Sciences Ltd.
The HIV community are facing new and unprecedented challenges as a result of an evolving healthcare landscape, changing HIV service provision and persisting health inequalities.
The HIV Collective is a programme created and funded by Gilead Sciences in response to this changing landscape. Through the programme we aim to support effective, tailored solutions to address the issues those living with HIV or at risk of HIV face today.
The HIV Collective is a natural evolution of HIV Age Positively which was set up in 2018 with the aim of supporting the HIV community to address challenges facing people as they begin to age with HIV. While we want to continue to support people to live and age well, this can only be achieved by acknowledging the new and emerging challenges facing people today.
The HIV Collective is designed to facilitate collaboration within the HIV community, providing a forum for the open exchange of ideas and offering support based on what the community needs most.
To provide fresh perspectives, we work with experts known for ground-breaking work inside and outside the HIV space.
These experts work alongside the HIV community to inspire new approaches and solutions to the greatest challenges facing those living with or at risk of HIV.
The HIV Collective was created under the banner of the HIV Age Positively programme, which has supported diverse projects across the UK and Ireland.
If you are interested in applying for funding through Gilead Giving, visit: www.gilead.co.uk/our-purpose/giving/grant-funding.
If you are interested in learning more about the work Gilead does with and for the HIV community, visit: www.gilead.co.uk/our-purpose/partnerships-and-community
Change doesn’t happen in isolation.
The HIV Collective creates a space for people to share ideas; together we can navigate new challenges to support people living with, or at risk of, HIV.
By working together for everyone, everywhere, we can support new and effective solutions to the issues those living with HIV face today.
You are now leaving www.hivcollective.co.uk and visiting a new site which is not owned or controlled by Gilead Sciences. Gilead Sciences is therefore not responsible for your interactions with the website or the information it provides.
